Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma
- 1 December 2004
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 41 (6), 999-1007
- https://doi.org/10.1016/j.jhep.2004.08.013
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Immunobiology and Gene-Based Immunotherapy of Hepatocellular CarcinomaZeitschrift für Gastroenterologie, 2003
- Hepatitis B virus‐induced defect of monocyte‐derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escapeImmunology, 2003
- Immunotherapy of hepatocellular carcinomaExpert Opinion on Biological Therapy, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Epidemiology of Primary Liver CancerSeminars in Liver Disease, 1999
- Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes.JCI Insight, 1992
- Suppression of NK activity of spleen cells by chicken fetal antigen present on Marek's disease lymphoblastoid cell line cellsInternational Journal of Cancer, 1987
- Inhibition of in vitro lymphocyte blastogenesis by chicken alpha-fetoprotein☆Comparative Immunology, Microbiology and Infectious Diseases, 1984
- Alpha-fetoprotein Suppresses Experimental allergic EncephalomyelitisJournal of Neuroimmunology, 1982
- Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.The Journal of Experimental Medicine, 1975